{
  "nctId": "NCT07181200",
  "briefTitle": "Urine Pneumococcal Antigen Project",
  "officialTitle": "Accelerating the Development of an Extended-specificity Multiplex Urine Immunoassay for the Diagnosis and Serotyping of Pneumococcal Pneumonia in High Carriage and Disease Burden Settings Like Malawi",
  "protocolDocument": {
    "nctId": "NCT07181200",
    "filename": "Prot_000.pdf",
    "label": "Study Protocol",
    "date": "2025-08-10",
    "uploadDate": "2025-09-11T08:32",
    "size": 628859,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT07181200/document/Prot_000.pdf",
    "hasProtocol": true,
    "hasSap": false,
    "hasIcf": false
  },
  "phase": [],
  "studyType": "OBSERVATIONAL",
  "enrollmentInfo": {
    "enrollmentCount": 350,
    "enrollmentType": "ESTIMATED"
  },
  "timeline": {
    "startDate": "2025-10",
    "completionDate": "2027-08",
    "primaryCompletionDate": "2027-01",
    "firstSubmitDate": "2025-09-12",
    "firstPostDate": "2025-09-18"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion criteria for healthy children in the community\n\n• Child aged between12-24 months.\n\nExclusion criteria for healthy children in the community\n\n* Presence of any of the following symptoms: fever, cough, difficulty in breathing or fast breathing.\n* Currently taking long-term antibiotic prophylaxis, TB treatment or immunosuppressive medications.\n* Diagnosis of an immunosuppressive illness, including HIV infection.\n* Hospital admission within the past six months.\n\nInclusion criteria for children with pneumonia in the community\n\n* Child aged between12-24 months.\n* Presence of all of the following symptoms: fever, cough, difficulty in breathing and fast breathing.\n* Participant has been prescribed antibiotics for treatment of a lower respiratory tract infection on this presentation.\n\nExclusion criteria for children with pneumonia in the community\n\n* Severe anaemia, with a recorded haemoglobin level \\< 70 grams per Litre.\n* Currently taking long-term antibiotic prophylaxis, TB treatment or immunosuppressive medications.\n* Diagnosis of an immunosuppressive illness, including HIV infection.\n* Hospital admission within the past six months.\n\nInclusion criteria for children hospitalised with pneumonia\n\n* Child aged between 12-24 months.\n* Presence of all of the following symptoms: fever, cough, difficulty in breathing and fast breathing.\n* Participant has been prescribed antibiotics for treatment of a lower respiratory tract infection on this presentation.\n\nExclusion criteria for children hospitalised with pneumonia\n\n* Severe anaemia, with a recorded haemoglobin level \\< 70 grams per Litre.\n* Currently taking long-term antibiotic prophylaxis, TB treatment or immunosuppressive medications.\n* Diagnosis of an immunosuppressive illness, including HIV infection.\n* Hospital admission within the past six months.\n\nInclusion criteria for children re-hospitalised with pneumonia\n\n* Child aged between12-24 months.\n* Presence of all of the following symptoms: fever, cough, difficulty in breathing and fast breathing.\n* Participant has been prescribed antibiotics for treatment of a lower respiratory tract infection on this presentation.\n* Hospital admission to ANY hospital with a lower respiratory tract infection within the past 3 months.\n\nExclusion criteria for children re-hospitalised with pneumonia\n\n* Severe anaemia, with a recorded haemoglobin level \\< 70 grams per Litre.\n* Currently taking long-term antibiotic prophylaxis, TB treatment or immunosuppressive medications.\n* Diagnosis of an immunosuppressive illness, including HIV infection.",
    "healthyVolunteers": true,
    "sex": "ALL",
    "minimumAge": "12 Months",
    "maximumAge": "24 Months",
    "stdAges": [
      "CHILD"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Serotype specific urinary pneumococcal antigen detection",
        "description": "Serotype-specific urinary pneumococcal antigen detection in urine samples taken at recruitment, using an extended-specificity multiplex urine immunoassay.",
        "timeFrame": "At the time of recruitment/participant enrolment."
      }
    ],
    "secondary": [
      {
        "measure": "Nasopharyngeal pneumococcal carriage",
        "description": "Detection of Streptococcus pneumoniae following culture of nasopharyngeal swab samples on Sheep Blood Agar with 5 µg/mL of Gentamicin (GBA).",
        "timeFrame": "At time of recruitment/enrolment."
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 0,
      "exclusionCount": 0,
      "totalCount": 0
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 1,
      "otherCount": 0,
      "totalCount": 2
    },
    "studyDesign": {
      "phases": [],
      "isRandomized": false,
      "isMasked": true
    },
    "overallComplexityScore": 30,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T05:06:11.775Z",
  "dataSource": "ClinicalTrials.gov API v2 - Ultimate Complete Collection"
}